A new bill is aiming to allow Pennsylvania liquor stores to sell recreational cannabis.
Pennsylvania lawmakers are working on three proposals hoping to achieve a variety of objectives: legalizing recreational cannabis, delivering social justice to individuals with minor cannabis convictions, and maximizing the economic benefits of a billion-dollar industry (1). With these bills, legislators hope to pave the way for a more equitable and flourishing future.
Two co-sponsorship memos are circulating the rounds in both the House and Senate. These memos are backed by State Senator Marty Flynn (D) of Lackawanna/Lehigh and State Representative David Delloso (D) of Delaware and propose approving the sale of cannabis through state-owned liquor stores. Strict age restrictions would be enforced to ensure cannabis products are only possessed and used by adults aged 21 and over. Included in these proposals is also allowing Pennsylvanian residents to grow and process up to six cannabis plants for personal use.
If cannabis sales are processed through the state system, the commonwealth would then secure a monopoly on both liquor and cannabis sales while also supporting the use of union labor. Delloso and Flynn’s proposals would be a step helping to foster greater economic equity and workers’ rights in their state of Pennsylvania.
State Representatives Donna Bullock (D) of Philadelphia and Dan Frankel (D) of Allegheny, are leading a new memo which targets generating revenue, safeguarding customers, economic equity, promoting social justice, and preventing substance abuse.
Both Bullock and Frankel feel that it is time to focus on a new perspective on the regulation and taxation of cannabis. With their proposal, the representatives would like to enhance the health and overall welfare of the citizens of Pennsylvania.
Through these various legislative measures, the stigma surrounding cannabis in the state of Pennsylvania, may begin to disappear.
Reference
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.